Niacinamide — predicted protein targets

Known targets — ChEMBL curated mechanism

KCNA1 KCNA10 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 KCNB1 KCNB2 KCNC1 KCNC2 KCNC3 KCNC4 KCND1 KCND2 KCND3 KCNF1 KCNG1 KCNG2 KCNG3 KCNG4 KCNH1 KCNH2 KCNH3 KCNH4 KCNH5 KCNH6 KCNH7 KCNH8 KCNQ1 KCNQ2 KCNQ3 KCNQ4 KCNQ5 KCNS1 KCNS2 KCNS3 KCNV1 KCNV2

The experimentally established mechanism targets of Niacinamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

	gene	UniProt	supporting neighbours	confidence
▸	F7	P08709	1/20	0.92

▸	F3	P13726	1/20	0.92

▸	SARM1	Q6SZW1	1/20	0.92

▸	SIRT2	Q8IXJ6	1/20	0.92

▸	SIRT6	Q8N6T7	1/20	0.92

▸	SIRT1	Q96EB6	1/20	0.92

▸	SIRT3	Q9NTG7	1/20	0.92

▸	SIRT5	Q9NXA8	1/20	0.92

▸	SIRT4	Q9Y6E7	1/20	0.92

▸	ALDH1A1	P00352	2/20	0.61

▸	APP	P05067	1/20	0.61

▸	GAA	P10253	1/20	0.61

▸	HCAR3	P49019	1/20	0.61

▸	HCAR2	Q8TDS4	1/20	0.61

▸	MKNK1	Q9BUB5	2/20	0.59

▸	MKNK2	Q9HBH9	2/20	0.59

▸	HDAC1	Q13547	2/20	0.55

▸	HDAC6	Q9UBN7	1/20	0.55

▸	POLB	P06746	2/20	0.52

▸	PLOD2	O00469	1/20	0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
Niacinamide SCHEMBL2926	0.96	—	—
Niacinamide SCHEMBL29624874	0.96	—	—
Niacinamide SCHEMBL19978192	0.96	—	—
Niacinamide SCHEMBL460466	0.96	F7 (1.00)	F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL23576525	0.94	F7 (0.96)	F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL1220080	0.94	F7 (0.96)	F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL9373225	0.94	F7 (0.96)	F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL11870926	0.94	F7 (0.96)	F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL20723610	0.94	—	—
Niacinamide SCHEMBL226257	0.94	F7 (0.96)	F7F3SARM1SIRT2SIRT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-2598878-A1	METHOD FOR IDENTIFYING A COMPOUND HAVING AN ANTIARRHYTHMIC EFFECT AS WELL AS USES RELATING THERETO	SANOFI (FR)	2013-06-05	—	—	EP	claimed
US-20130123143-A1	METHOD FOR IDENTIFYING A COMPOUND HAVING AN ANTIARRHYTHMIC EFFECT AS WELL AS USES RELATING THERETO	SANOFI (FR)	2013-05-16	—	—	US	claimed
WO-2012013619-A1	METHOD FOR IDENTIFYING A COMPOUND HAVING AN ANTIARRHYTHMIC EFFECT AS WELL AS USES RELATING THERETO	SANOFI (FR)	2012-02-02	—	—	WO	claimed
EP-2413140-A1	Method for identifying a compound having an antiarrhythmic effect as well as uses relating thereto	SANOFI (FR)	2012-02-01	—	—	EP	claimed
EP-2598878-A1	METHOD FOR IDENTIFYING A COMPOUND HAVING AN ANTIARRHYTHMIC EFFECT AS WELL AS USES RELATING THERETO	SANOFI (FR)	2013-06-05	—	—	EP	disclosed
US-20130123143-A1	METHOD FOR IDENTIFYING A COMPOUND HAVING AN ANTIARRHYTHMIC EFFECT AS WELL AS USES RELATING THERETO	SANOFI (FR)	2013-05-16	—	—	US	disclosed
WO-2012013619-A1	METHOD FOR IDENTIFYING A COMPOUND HAVING AN ANTIARRHYTHMIC EFFECT AS WELL AS USES RELATING THERETO	SANOFI (FR)	2012-02-02	—	—	WO	disclosed
EP-2413140-A1	Method for identifying a compound having an antiarrhythmic effect as well as uses relating thereto	SANOFI (FR)	2012-02-01	—	—	EP	disclosed